These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 16879964)
1. A novel class of AMPA receptor allosteric modulators. Part 1: design, synthesis, and SAR of 3-aryl-4-cyano-5-substituted-heteroaryl-2-carboxylic acid derivatives. Fernandez MC; Castaño A; Dominguez E; Escribano A; Jiang D; Jimenez A; Hong E; Hornback WJ; Nisenbaum ES; Rankl N; Tromiczak E; Vaught G; Zarrinmayeh H; Zimmerman DM Bioorg Med Chem Lett; 2006 Oct; 16(19):5057-61. PubMed ID: 16879964 [TBL] [Abstract][Full Text] [Related]
2. A novel class of positive allosteric modulators of AMPA receptors: design, synthesis, and structure-activity relationships of 3-biphenyl-4-yl-4-cyano-5-ethyl-1-methyl-1H-pyrrole-2-carboxylic acid, LY2059346. Zarrinmayeh H; Tromiczak E; Zimmerman DM; Rankl N; Ho KH; Dominguez E; Castaño A; Escribano A; Fernandez C; Jimenez A; Hornback WJ; Nisenbaum ES Bioorg Med Chem Lett; 2006 Oct; 16(19):5203-6. PubMed ID: 16872827 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and structure-activity relationships of novel bicyclic azole-amines as negative allosteric modulators of metabotropic glutamate receptor 5. Burdi DF; Hunt R; Fan L; Hu T; Wang J; Guo Z; Huang Z; Wu C; Hardy L; Detheux M; Orsini MA; Quinton MS; Lew R; Spear K J Med Chem; 2010 Oct; 53(19):7107-18. PubMed ID: 20809633 [TBL] [Abstract][Full Text] [Related]
4. N-heterocyclic derived M1 positive allosteric modulators. Kuduk SD; Di Marco CN; Cofre V; Pitts DR; Ray WJ; Ma L; Wittmann M; Veng L; Seager MA; Koeplinger K; Thompson CD; Hartman GD; Bilodeau MT Bioorg Med Chem Lett; 2010 Feb; 20(4):1334-7. PubMed ID: 20097564 [TBL] [Abstract][Full Text] [Related]
5. New fluorinated 1,2,4-benzothiadiazine 1,1-dioxides: discovery of an orally active cognitive enhancer acting through potentiation of the 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors. Francotte P; Goffin E; Fraikin P; Lestage P; Van Heugen JC; Gillotin F; Danober L; Thomas JY; Chiap P; Caignard DH; Pirotte B; de Tullio P J Med Chem; 2010 Feb; 53(4):1700-11. PubMed ID: 20108934 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and pharmacology of novel 7-substituted 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides as positive allosteric modulators of AMPA receptors. Francotte P; Tullio Pd; Goffin E; Dintilhac G; Graindorge E; Fraikin P; Lestage P; Danober L; Thomas JY; Caignard DH; Pirotte B J Med Chem; 2007 Jun; 50(13):3153-7. PubMed ID: 17552506 [TBL] [Abstract][Full Text] [Related]
7. Substituted benzoxazinones as potent positive allosteric AMPA receptor modulators: part II. Mueller R; Rachwal S; Tedder ME; Li YX; Zhong S; Hampson A; Ulas J; Varney M; Nielsson L; Rogers G Bioorg Med Chem Lett; 2011 Jul; 21(13):3927-30. PubMed ID: 21636273 [TBL] [Abstract][Full Text] [Related]
8. Benzotriazinone and benzopyrimidinone derivatives as potent positive allosteric AMPA receptor modulators. Mueller R; Rachwal S; Lee S; Zhong S; Li YX; Haroldsen P; Herbst T; Tanimura S; Varney M; Johnson S; Rogers G; Street LJ Bioorg Med Chem Lett; 2011 Oct; 21(20):6170-5. PubMed ID: 21889339 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and AMPA receptor antagonistic activity of a novel 6-nitro-3-oxoquinoxaline-2-carboxylic acid with a substituted phenyl group at the 7 position. Takano Y; Shiga F; Asano J; Ando N; Uchiki H; Fukuchi K; Anraku T Bioorg Med Chem; 2005 Oct; 13(20):5841-63. PubMed ID: 15993606 [TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of a novel series of 1,2-disubstituted cyclopentanes as small, potent potentiators of 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid (AMPA) receptors. Shepherd TA; Aikins JA; Bleakman D; Cantrell BE; Rearick JP; Simon RL; Smith EC; Stephenson GA; Zimmerman DM; Mandelzys A; Jarvie KR; Ho K; Deverill M; Kamboj RK J Med Chem; 2002 May; 45(10):2101-11. PubMed ID: 11985477 [TBL] [Abstract][Full Text] [Related]
11. Positive allosteric modulators of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor. Grove SJ; Jamieson C; Maclean JK; Morrow JA; Rankovic Z J Med Chem; 2010 Oct; 53(20):7271-9. PubMed ID: 20839777 [No Abstract] [Full Text] [Related]
12. Design and structure-activity relationship of heterocyclic analogs of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones as inhibitors of receptor tyrosine kinases. Frazier K; Jazan E; McBride CM; Pecchi S; Renhowe PA; Shafer CM; Taylor C; Bussiere D; He MM; Jansen JM; Lapointe G; Ma S; Vora J; Wiesmann M Bioorg Med Chem Lett; 2006 Apr; 16(8):2247-51. PubMed ID: 16446087 [TBL] [Abstract][Full Text] [Related]
13. Chemical switch of a metabotropic glutamate receptor 2 silent allosteric modulator into dual metabotropic glutamate receptor 2/3 negative/positive allosteric modulators. Schann S; Mayer S; Franchet C; Frauli M; Steinberg E; Thomas M; Baron L; Neuville P J Med Chem; 2010 Dec; 53(24):8775-9. PubMed ID: 21105727 [TBL] [Abstract][Full Text] [Related]
14. Benzobistriazinones and related heterocyclic ring systems as potent, orally bioavailable positive allosteric AMPA receptor modulators. Mueller R; Rachwal S; Varney MA; Johnson SA; Alisala K; Zhong S; Li YX; Haroldsen P; Herbst T; Street LJ Bioorg Med Chem Lett; 2011 Dec; 21(24):7455-9. PubMed ID: 22056742 [TBL] [Abstract][Full Text] [Related]
15. A novel series of positive modulators of the AMPA receptor: structure-based lead optimization. Jamieson C; Campbell RA; Cumming IA; Gillen KJ; Gillespie J; Kazemier B; Kiczun M; Lamont Y; Lyons AJ; Maclean JK; Martin F; Moir EM; Morrow JA; Pantling J; Rankovic Z; Smith L Bioorg Med Chem Lett; 2010 Oct; 20(20):6072-5. PubMed ID: 20817521 [TBL] [Abstract][Full Text] [Related]
16. Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators. Kuduk SD; Di Marco CN; Chang RK; Ray WJ; Ma L; Wittmann M; Seager MA; Koeplinger KA; Thompson CD; Hartman GD; Bilodeau MT Bioorg Med Chem Lett; 2010 Apr; 20(8):2533-7. PubMed ID: 20303264 [TBL] [Abstract][Full Text] [Related]
17. Benzoxazinones as potent positive allosteric AMPA receptor modulators: part I. Mueller R; Li YX; Hampson A; Zhong S; Harris C; Marrs C; Rachwal S; Ulas J; Nielsson L; Rogers G Bioorg Med Chem Lett; 2011 Jul; 21(13):3923-6. PubMed ID: 21636275 [TBL] [Abstract][Full Text] [Related]
18. Heterocyclic modulators of the NMDA receptor. Pellicciari R; Natalini B; Costantino G; Garzon A; Luneia R; Mahmoud MR; Marinozzi M; Roberti M; Rosato GC; Shiba SA Farmaco; 1993 Feb; 48(2):151-7. PubMed ID: 8494596 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonists. Yu Y; Dwyer MP; Chao J; Aki C; Chao J; Purakkattle B; Rindgen D; Bond R; Mayer-Ezel R; Jakway J; Qiu H; Hipkin RW; Fossetta J; Gonsiorek W; Bian H; Fan X; Terminelli C; Fine J; Lundell D; Merritt JR; He Z; Lai G; Wu M; Taveras A Bioorg Med Chem Lett; 2008 Feb; 18(4):1318-22. PubMed ID: 18242983 [TBL] [Abstract][Full Text] [Related]
20. 1,3,4-Oxadiazoline derivatives as novel potential inhibitors targeting chitin biosynthesis: design, synthesis and biological evaluation. Ke S; Liu F; Wang N; Yang Q; Qian X Bioorg Med Chem Lett; 2009 Jan; 19(2):332-5. PubMed ID: 19091556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]